Global Markets
Home›Global Markets›North America›Trump administration delays could disrupt HIV research…
Trump administration delays could disrupt HIV research funding
The Trump administration is delaying actions tied to funding for HIV research networks, according to the New York Times Business.
The networks also work on treatments and preventions for other infectious diseases and helped test the Covid vaccine.
← Newer storyKenzoll Capital plans $50M restart of Namibia’s Elizabeth Bay diamond…Older story →Cardano launches programmable token standard with issuer controls
More like this
Global MarketsAlberta to vote on independence referendum on 19 October